Skip to main content

Advertisement

Log in

Pharmacologic treatment of fibromyalgia

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bennett R: The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002, 28:181–199.

    Article  PubMed  Google Scholar 

  2. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160–172.

    Article  PubMed  CAS  Google Scholar 

  3. Goldenberg DL: Office management of fibromyalgia. Rheum Dis Clin North Am 2002, 28:437–446.

    Article  PubMed  Google Scholar 

  4. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle AA: Randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994, 21:714–720.

    PubMed  CAS  Google Scholar 

  5. Burckhardt CS, Bjelle AA: Education programs for fibromyalgia patients: description and evaluation. Baillieres Clin Rheumatol 1994, 8:935–955.

    Article  PubMed  CAS  Google Scholar 

  6. Bennett R: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999, 74:385–398. important article summarizing the current evidence to place FM among the central pain states, although acknowledging the importance of peripheral pain generators.

    PubMed  CAS  Google Scholar 

  7. Barkhuizen A: Rational and targeted pharmacologic treatment of fibromyalgia. Rheum Dis Clin North Am 2002, 28:261–290.

    Article  PubMed  Google Scholar 

  8. Arnold L: Systemic therapies for chronic pain. In Fibromyalgia and Other Central Pain Syndromes. Edited by Wallace D. Baltimore: Lippincott Williams & Wilkins; 2005:365–388. eview of controlled trials of the pharmacologic treatment of FM, with a discussion of current issues that remain to be addressed in further research.

    Google Scholar 

  9. Goldbenberg D, Smith N: Fibromyalgia, rheumatologists, and the medical literature: a shaky alliance. J Rheumatol 2003, 30:151–153.

    Google Scholar 

  10. Goldenberg D, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA 2004, 292:2388–2395. up-to-date summary of evidence-based guidelines for the treatment of FM.

    Article  PubMed  CAS  Google Scholar 

  11. Arnold LM, Keck PE: Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000, 41:104–113.

    Article  PubMed  CAS  Google Scholar 

  12. O’Malley PG, Balden E, Tomkins G, et al.: Treatment of fibromyalgia with antidepressants. J Gen Intern Med 2000, 15:659–666.

    Article  PubMed  CAS  Google Scholar 

  13. Tofferi JK, Jackson JL, O’Malley PG: Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004, 51:9–13.

    Article  PubMed  CAS  Google Scholar 

  14. Wolfe F, Cathey MA, Hawley DJ: Double-blind, placebo-controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994, 23:255–259.

    PubMed  CAS  Google Scholar 

  15. Arnold LM, Hess EV, Hudson JI, et al.: Randomized, placebocontrolled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002, 112:191–197.

    Article  PubMed  CAS  Google Scholar 

  16. Goldenberg D, Mayskiy M, Mossey CJ, et al.: Randomized, double-blind, crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996, 39:1852–1859.

    Article  PubMed  CAS  Google Scholar 

  17. Cantini F, Bellandi F, Niccolo L, et al.: Fluoxetine combined with cyclobenzaprine in the treatment of fibromyalgia. Minerva Med 1994, 85:97–100.

    PubMed  CAS  Google Scholar 

  18. Zijsltra TR, Barendregt PJ, Van de Laar MA: Venlafaxine in fibromyalgia: results of a randomized, placebo-controlled, double-blind trial [Abstract]. Arthritis Rheum 2002, 46:S105.

    Google Scholar 

  19. Dwight MM, Arnold LM, O’Brien H, et al.: An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998, 39:14–17.

    PubMed  CAS  Google Scholar 

  20. Sayar K, Aksu G, Ak I, Tosum M: Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003, 37:1561–1565.

    Article  PubMed  CAS  Google Scholar 

  21. Gendreau RM, Mease PJ, Rao SR, et al.: Milnacipran: a potential new treatment of fibromyalgia [Abstract]. Arthritis Rheum 2003, 48:S616.

    Google Scholar 

  22. Arnold LM, Lu Y, Crofford LJ, et al.: A double-blind, multicenter trial comparing duloxetine to placebo in the treatment of fibromyalgia with or without major depressive disorder. Arthritis Rheum 2004, 50:2974–2984. ely trial of large pharmaceutically sponsored agents in FM with encouraging results.

    Article  PubMed  CAS  Google Scholar 

  23. Rossy LA, Buckelew SP, Dorr N, et al.: A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999, 21:180–191.

    Article  PubMed  CAS  Google Scholar 

  24. Russell IJ: Fibromyalgia syndrome: approaches to management. Bull Rheum Dis 1996, 45:1–4.

    PubMed  CAS  Google Scholar 

  25. Wolfe F, Zhao S, Lane N: Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients. Arthritis Rheum 2000, 43:378–385.

    Article  PubMed  CAS  Google Scholar 

  26. Goldenberg DL, Felson DT, Dinerman HA: Randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986, 29:1371–1377.

    Article  PubMed  CAS  Google Scholar 

  27. Biasi G, Manca S, Manganelli S, Marcolongo R: Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998, 18:13–19.

    PubMed  CAS  Google Scholar 

  28. Russell J, Kamin M, Bennet RM, et al.: Efficacy of tramadol in the treatment of pain in fibromyalgia. J Clin Rheumatol 2000, 6:250–257.

    Article  PubMed  Google Scholar 

  29. Bennett RM, Kamin M, Karin R, Rosenthal N: Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain. Am J Med 2003, 114:537–545.

    Article  PubMed  CAS  Google Scholar 

  30. Petrone D, Kamin M, Olson W: Slowing the titration rate of tramadol HCL reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind, randomized trial. J Clin Pharm Ther 1999, 24:115–123.

    Article  PubMed  CAS  Google Scholar 

  31. Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H: Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 2000, 20:629–634.

    Article  PubMed  CAS  Google Scholar 

  32. Mahowald M, Singh JA, Majeski P: Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005, 52:312–321.

    Article  PubMed  Google Scholar 

  33. Crofford L, Rowbotham M, Mease P, et al.: Pregabalin for the treatment of fibromyalgia syndrome. Arthritis Rheum 2005, 52:1264–1273. important recent trial of a large pharmaceutically sponsored agent

    Article  PubMed  CAS  Google Scholar 

  34. Spath M, Stratz T, Neeck G, et al.: Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 2004, 33:267–270.

    Article  PubMed  CAS  Google Scholar 

  35. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990, 18:201–209.

    PubMed  CAS  Google Scholar 

  36. Volkmann H, Norregaard J, Jacobsen S, et al.: Double-blind, placebo-controlled, crossover study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. Scand J Rheumatol 1997, 26:206–211.

    Article  PubMed  CAS  Google Scholar 

  37. Bennett RM, Clark SC, Walczyk JA: Randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998, 104:227–231.

    Article  PubMed  CAS  Google Scholar 

  38. Cote KA, Moldofsky H: Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol 1997, 24:2014–2023.

    CAS  Google Scholar 

  39. Drewes AM, Nielsen KD, Taagholt SJ, et al.: Sleep intensity in fibromyalgia: focus on the microstructure of the sleep process. Br J Rheumatol 1995, 34:629–635.

    Article  PubMed  CAS  Google Scholar 

  40. Yunus MB, Aldag JC: Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. Br Med J 1996, 312:1339.

    CAS  Google Scholar 

  41. Lin SC, Kaplan J, Burger CD, Fredrickson PA: Effect of pramipexole in the treatment of resistant restless legs syndrome. Mayo Clin Proc 1998, 73:447–450.

    Article  Google Scholar 

  42. Becker PM, Ondo W, Sharon D: Encouraging initial response of restless legs syndrome to pramipexole. Neurology 1998, 51:1221–1223.

    PubMed  CAS  Google Scholar 

  43. Simon GE, VonKorff M: Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997, 154:1417–1423.

    PubMed  CAS  Google Scholar 

  44. Coward DM: Tizanidine: neuropharmacology and mechanisms of action. Neurology 1994, 44:S6-S10.

    PubMed  CAS  Google Scholar 

  45. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000, 54:1166–1175.

    Google Scholar 

  46. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998, 43:88–97.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baker, K., Barkhuizen, A. Pharmacologic treatment of fibromyalgia. Current Science Inc 9, 301–306 (2005). https://doi.org/10.1007/s11916-005-0003-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-005-0003-x

Keywords

Navigation